메뉴 건너뛰기




Volumn 63, Issue 9, 2004, Pages 1075-1078

Treatment with tumour necrosis factor α antagonists in patients with rheumatoid arthritis induces anticardiolipin antibodies

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CARDIOLIPIN ANTIBODY; ETANERCEPT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLIXIMAB; METHOTREXATE;

EID: 4344599220     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2003.018093     Document Type: Article
Times cited : (105)

References (27)
  • 1
    • 0031660364 scopus 로고    scopus 로고
    • Therapeutic efficacy of multiple intravenous infusions of anti-tumour necrosis factor α monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis
    • Maini RN, Breedveld FC, Kalden JR, Smolen JS, Davis D, Macfarlane JD, et al. Therapeutic efficacy of multiple intravenous infusions of anti-tumour necrosis factor α monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum 1998;41:1552-6.
    • (1998) Arthritis Rheum , vol.41 , pp. 1552-1556
    • Maini, R.N.1    Breedveld, F.C.2    Kalden, J.R.3    Smolen, J.S.4    Davis, D.5    Macfarlane, J.D.6
  • 2
    • 0033524159 scopus 로고    scopus 로고
    • Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomised phase III trial
    • Maini RN, St Clair EW, Breedveld F, Furst D, Kalden J, Weisman M, et al. Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. Lancet 1999;354:1932-9.
    • (1999) Lancet , vol.354 , pp. 1932-1939
    • Maini, R.N.1    St Clair, E.W.2    Breedveld, F.3    Furst, D.4    Kalden, J.5    Weisman, M.6
  • 4
    • 0028143212 scopus 로고
    • Repeated therapy with monoclonal antibody to tumour necrosis factor-α (cA2) in patients with rheumatoid arthritis
    • Elliott MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Bijl H, et al. Repeated therapy with monoclonal antibody to tumour necrosis factor-α (cA2) in patients with rheumatoid arthritis. Lancet 1994;344:1125-7.
    • (1994) Lancet , vol.344 , pp. 1125-1127
    • Elliott, M.J.1    Maini, R.N.2    Feldmann, M.3    Long-Fox, A.4    Charles, P.5    Bijl, H.6
  • 5
  • 6
    • 0027438710 scopus 로고
    • Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor-α
    • Elliott MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Katsikis P, et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor-α. Arthritis Rheum 1993;36:1681-90.
    • (1993) Arthritis Rheum , vol.36 , pp. 1681-1690
    • Elliott, M.J.1    Maini, R.N.2    Feldmann, M.3    Long-Fox, A.4    Charles, P.5    Katsikis, P.6
  • 7
    • 0033611472 scopus 로고    scopus 로고
    • A trial of etanercept, a recombinant tumour necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate
    • Weinblatt ME, Kremer JM, Bonkhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, et al. A trial of etanercept, a recombinant tumour necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 1999;340:253-9.
    • (1999) N Engl J Med , vol.340 , pp. 253-259
    • Weinblatt, M.E.1    Kremer, J.M.2    Bonkhurst, A.D.3    Bulpitt, K.J.4    Fleischmann, R.M.5    Fox, R.I.6
  • 9
    • 0013511183 scopus 로고    scopus 로고
    • Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein
    • Moreland LW, Baumgartner SW, Schiff MH, Tindall EA, Fleischmann RM, Weaver AL, et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med 1997;337:141-7.
    • (1997) N Engl J Med , vol.337 , pp. 141-147
    • Moreland, L.W.1    Baumgartner, S.W.2    Schiff, M.H.3    Tindall, E.A.4    Fleischmann, R.M.5    Weaver, A.L.6
  • 11
    • 0033763979 scopus 로고    scopus 로고
    • Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor-α: Findings in open-label and randomised placebo-controlled trials
    • Charles PJ, Smeenk RJ, De Jong J, Feldmann M, Maini RN. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor-α: findings in open-label and randomised placebo-controlled trials. Arthritis Rheum 2000;43:2383-90.
    • (2000) Arthritis Rheum , vol.43 , pp. 2383-2390
    • Charles, P.J.1    Smeenk, R.J.2    De Jong, J.3    Feldmann, M.4    Maini, R.N.5
  • 12
    • 0000337774 scopus 로고
    • Serological effects of repeated doses of an engineered human anti-TNF-α antibody, CDP571, in patients with rheumatoid arthritis
    • Rankin ECC, Choy EHS, Ehrenstein MR, Ravirajan CT, Sopwith M, Vetterlein O, et al. Serological effects of repeated doses of an engineered human anti-TNF-α antibody, CDP571, in patients with rheumatoid arthritis [abstract]. Arthritis Rheum 1995;38(suppl):S279.
    • (1995) Arthritis Rheum , vol.38 , Issue.SUPPL.
    • Rankin, E.C.C.1    Choy, E.H.S.2    Ehrenstein, M.R.3    Ravirajan, C.T.4    Sopwith, M.5    Vetterlein, O.6
  • 13
    • 0036207308 scopus 로고    scopus 로고
    • Anticardiolipin antibodies in rheumatoid patients treated with etanercept or conventional combination therapy: Direct and indirect evidence of a passible association with infections
    • Ferraccioli GF, Mecchia F, Di Poi E, Fabris M. Anticardiolipin antibodies in rheumatoid patients treated with etanercept or conventional combination therapy: direct and indirect evidence of a passible association with infections. Ann Rheum Dis 2002;82:358-61.
    • (2002) Ann Rheum Dis , vol.82 , pp. 358-361
    • Ferraccioli, G.F.1    Mecchia, F.2    Di Poi, E.3    Fabris, M.4
  • 14
    • 0025075078 scopus 로고
    • Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population
    • Shi W, Krilis SA, Chong BH, Gordon S, Chesterman CN. Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population. Aust N Z J Med 1990;20:231-6.
    • (1990) Aust N Z J Med , vol.20 , pp. 231-236
    • Shi, W.1    Krilis, S.A.2    Chong, B.H.3    Gordon, S.4    Chesterman, C.N.5
  • 15
    • 0024381408 scopus 로고
    • The prevalence of anticardiolipin antibodies in a healthy elderly population and its association with antinuclear antibodies
    • Fields RA, Toubbeh H, Searles RP, Bankhurst AD. The prevalence of anticardiolipin antibodies in a healthy elderly population and its association with antinuclear antibodies. J Rheumatol 1989;16:623-5.
    • (1989) J Rheumatol , vol.16 , pp. 623-625
    • Fields, R.A.1    Toubbeh, H.2    Searles, R.P.3    Bankhurst, A.D.4
  • 17
    • 0028108605 scopus 로고
    • Anticardiolipin antibodies in rheumatoid arthritis: Their relation to rheumatoid nodules and cutaneous vascular manifestations
    • Wolf P, Gretler J, Aglas F, Auer-Grumbach P, Rainer F. Anticardiolipin antibodies in rheumatoid arthritis: their relation to rheumatoid nodules and cutaneous vascular manifestations. Br J Dermatol 1994;131:48-51.
    • (1994) Br J Dermatol , vol.131 , pp. 48-51
    • Wolf, P.1    Gretler, J.2    Aglas, F.3    Auer-Grumbach, P.4    Rainer, F.5
  • 19
    • 0023945481 scopus 로고
    • The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
    • Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
    • (1988) Arthritis Rheum , vol.31 , pp. 315-324
    • Arnett, F.C.1    Edworthy, S.M.2    Bloch, D.A.3    McShane, D.J.4    Fries, J.F.5    Cooper, N.S.6
  • 20
    • 0020188574 scopus 로고
    • The dimensions of health outcomes: The Health Assessment Questionnaire, Disability and Pain Scale
    • Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: the Health Assessment Questionnaire, Disability and Pain Scale. J Rheumatol 1982;9:789-93.
    • (1982) J Rheumatol , vol.9 , pp. 789-793
    • Fries, J.F.1    Spitz, P.W.2    Young, D.Y.3
  • 21
    • 0027238592 scopus 로고
    • The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials
    • Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 1993;36:729-40.
    • (1993) Arthritis Rheum , vol.36 , pp. 729-740
    • Felson, D.T.1    Anderson, J.J.2    Boers, M.3    Bombardier, C.4    Chernoff, M.5    Fried, B.6
  • 22
    • 0027420099 scopus 로고
    • Development of a disease activity score based on judgment in clinical practice by rheumatologists
    • van der Heijde DM, van't Hof M, van Riel PL, van de Putte LB. Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol 1993;20:579-81.
    • (1993) J Rheumatol , vol.20 , pp. 579-581
    • Van Der Heijde, D.M.1    Van't Hof, M.2    Van Riel, P.L.3    Van De Putte, L.B.4
  • 23
    • 0024578482 scopus 로고
    • Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody
    • Lockshin MD, Druzin ML, Qamar T. Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am J Obstet Gynecol 1989;160:439-43.
    • (1989) Am J Obstet Gynecol , vol.160 , pp. 439-443
    • Lockshin, M.D.1    Druzin, M.L.2    Qamar, T.3
  • 24
    • 0031418574 scopus 로고    scopus 로고
    • Pro- and anti-inflammatory cytokines in rheumatoid arthritis
    • Isomäki P, Punnonen J. Pro- and anti-inflammatory cytokines in rheumatoid arthritis. Ann Med 1997;29:499-507.
    • (1997) Ann Med , vol.29 , pp. 499-507
    • Isomäki, P.1    Punnonen, J.2
  • 25
    • 0036676817 scopus 로고    scopus 로고
    • Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis: Evidence for a pathogenetic role of B cells
    • De Vita S, Zaja F, Sacco S, De Candia A, Fanin R, Ferraccioli G. Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis: evidence for a pathogenetic role of B cells. Arthritis Rheum 2002;46:2029-33.
    • (2002) Arthritis Rheum , vol.46 , pp. 2029-2033
    • De Vita, S.1    Zaja, F.2    Sacco, S.3    De Candia, A.4    Fanin, R.5    Ferraccioli, G.6
  • 26
    • 0036674876 scopus 로고    scopus 로고
    • B cell-ablative therapy far the treatment of autoimmune disease
    • Dhavalkumar DP. B cell-ablative therapy far the treatment of autoimmune disease. Arthritis Rheum 2002;46:1984-5.
    • (2002) Arthritis Rheum , vol.46 , pp. 1984-1985
    • Dhavalkumar, D.P.1
  • 27
    • 0036269445 scopus 로고    scopus 로고
    • The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: Results from ATTRACT, a multicenter, randomised, double-blind, placebo controlled trial
    • St Clair EW, Wagner CL, Fasanmade AA, Wang B, Schaible T, Kavanaugh A, et al. The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: results from ATTRACT, a multicenter, randomised, double-blind, placebo controlled trial. Arthritis Rheum 2002;46:1451-9.
    • (2002) Arthritis Rheum , vol.46 , pp. 1451-1459
    • St Clair, E.W.1    Wagner, C.L.2    Fasanmade, A.A.3    Wang, B.4    Schaible, T.5    Kavanaugh, A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.